Laureate Pharma Appoints Kathleen Bloch as CFO
Laureate Pharma, a biopharmaceutical contract development and manufacturing organisation, has hired Kathleen Bloch as chief financial officer (CFO). Bloch’s primary objective is to increase capital and provide a platform for the continued growth of the company. Her plans include the development of a robust, interactive financial reporting systems, including a project-facing system and a materials management system that will further client relationships.
As CFO she is responsible for finance, accounting and information technology activities in addition to serving as a member of the company’s management committee. Bloch has taken direct responsibility for Laureate’s relationships with banks, insurance companies, accounting firms and other external business vendors as well as relationships with law firms and investors.
Since 2007 Bloch was employed by PC Group, where she served as chief operating officer (COO) and CFO. Prior to this, Bloch managed day-to-day operations for The Silverman Group, a real estate and investment company. For 10 years prior, she was employed by Silver Line Building Products Corporation, a privately-held manufacturer of vinyl windows. She served as CFO from 1999 until 2006, when Andersen Corporation acquired the company, a manufacturer of windows. She holds a MBA degree and a BSc Accounting degree from LaSalle University.